Objective To provide an overview of the etiology, prevention, diagnosis, treatment, and long-
term survivorship concerns surrounding cervical cancer. Data Sources A review of articles …

Cervical cancer remains a leading cause of cancer death in women, seriously threatening
their physical and mental health. It is an easily preventable cancer with early screening and …

Background Pembrolizumab has efficacy in programmed death ligand 1 (PD-L1)–positive
metastatic or unresectable cervical cancer that has progressed during chemotherapy. We …

Since the publication of the 2018 FIGO Cancer Report, giant strides have been made in the
global effort to reduce the burden of cervical cancer, with the World Health Organization …

Background Few effective second-line treatments exist for women with recurrent or
metastatic cervical cancer. Accordingly, we aimed to evaluate the efficacy and safety of …

PURPOSE Nivolumab was assessed in patients with virus-associated tumors in the phase
I/II CheckMate 358 trial (ClinicalTrials. gov identifier: NCT02488759). We report on patients …

PURPOSE Balstilimab (antiprogrammed death-1) and zalifrelimab (anticytotoxic T-
lymphocyte–associated antigen-4) are two new checkpoint inhibitors emerging as promising …

Cervical cancer constitutes a significant health burden for women globally. While most
patients with early-stage disease can be cured with radical surgery or chemoradiotherapy …

Polyphenolic flavonoids are considered natural, non-toxic chemopreventers, which are most
commonly derived from plants, fruits, and vegetables. Most of these polyphenolics exhibit …

Objectives The recommendations cover indications for MRI examination including
acquisition planes, patient preparation, imaging protocol including multi-parametric …